Annual accounts receivable:
$1.06B+$95.11M(+9.88%)Summary
- As of today (September 17, 2025), RDY annual accounts receivable is $1.06 billion, with the most recent change of +$95.11 million (+9.88%) on March 31, 2025.
- During the last 3 years, RDY annual accounts receivable has risen by +$176.80 million (+20.07%).
- RDY annual accounts receivable is now at all-time high.
Performance
RDY Accounts receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly accounts receivable:
$1.11B+$51.46M(+4.86%)Summary
- As of today (September 17, 2025), RDY quarterly accounts receivable is $1.11 billion, with the most recent change of +$51.46 million (+4.86%) on June 30, 2025.
- Over the past year, RDY quarterly accounts receivable has increased by +$136.92 million (+14.08%).
- RDY quarterly accounts receivable is now at all-time high.
Performance
RDY Quarterly accounts receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Accounts receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
RDY Accounts receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +9.9% | +14.1% |
| 3 y3 years | +20.1% | +19.7% |
| 5 y5 years | +59.2% | +79.9% |
RDY Accounts receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +20.1% | at high | +32.1% |
| 5 y | 5-year | at high | +59.2% | at high | +79.9% |
| alltime | all time | at high | +5073.2% | at high | +1892.4% |
RDY Accounts receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $1.11B(+4.9%) |
| Mar 2025 | $1.06B(+9.9%) | $1.06B(+5.0%) |
| Sep 2024 | - | $1.01B(+3.6%) |
| Jun 2024 | - | $972.42M(+1.0%) |
| Mar 2024 | $962.78M(+9.2%) | $962.78M(+2.2%) |
| Dec 2023 | - | $942.36M(+12.2%) |
| Sep 2023 | - | $839.61M(-10.7%) |
| Jun 2023 | - | $939.77M(+6.5%) |
| Mar 2023 | $882.00M(+0.1%) | $882.00M(-2.8%) |
| Dec 2022 | - | $907.12M(-4.1%) |
| Sep 2022 | - | $946.35M(+2.1%) |
| Jun 2022 | - | $927.08M(+5.2%) |
| Mar 2022 | $881.08M(+29.8%) | $881.08M(+4.9%) |
| Dec 2021 | - | $840.05M(-9.1%) |
| Sep 2021 | - | $924.33M(+12.6%) |
| Jun 2021 | - | $820.96M(+20.9%) |
| Mar 2021 | $678.96M(+2.2%) | $678.96M(-6.7%) |
| Dec 2020 | - | $727.61M(+7.2%) |
| Sep 2020 | - | $678.73M(+10.0%) |
| Jun 2020 | - | $616.76M(-7.2%) |
| Mar 2020 | $664.60M(+15.5%) | $664.60M(+6.8%) |
| Dec 2019 | - | $622.04M(+8.3%) |
| Sep 2019 | - | $574.27M(+4.7%) |
| Jun 2019 | - | $548.26M(-4.7%) |
| Mar 2019 | $575.52M(-7.6%) | $575.52M(+8.0%) |
| Dec 2018 | - | $532.72M(-16.3%) |
| Sep 2018 | - | $636.43M(-9.0%) |
| Jun 2018 | - | $699.51M(+12.3%) |
| Mar 2018 | $622.75M(+6.2%) | $622.75M(-6.3%) |
| Dec 2017 | - | $664.91M(+2.9%) |
| Sep 2017 | - | $646.13M(+1.5%) |
| Jun 2017 | - | $636.47M(+8.6%) |
| Mar 2017 | $586.20M(-6.0%) | $586.20M(-3.2%) |
| Dec 2016 | - | $605.68M(+9.2%) |
| Sep 2016 | - | $554.82M(+5.5%) |
| Jun 2016 | - | $526.10M(-15.7%) |
| Mar 2016 | $623.75M(-4.2%) | $623.75M(-4.4%) |
| Sep 2015 | - | $652.45M(+0.2%) |
| Mar 2015 | $651.23M(+17.8%) | $651.23M(+6.6%) |
| Sep 2014 | - | $610.72M(+10.4%) |
| Mar 2014 | $553.04M(-6.0%) | $553.04M(+4.0%) |
| Sep 2013 | - | $531.66M(-9.6%) |
| Mar 2013 | $588.28M(+18.3%) | $588.28M(+18.2%) |
| Sep 2012 | - | $497.64M(+0.0%) |
| Mar 2012 | $497.40M | $497.40M(+18.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2011 | - | $420.00M(+6.3%) |
| Mar 2011 | $394.93M(+52.9%) | $394.93M(+32.7%) |
| Sep 2010 | - | $297.61M(+8.3%) |
| Jun 2010 | - | $274.79M(+3.1%) |
| Mar 2010 | $258.31M(-9.0%) | $266.59M(+6.6%) |
| Dec 2009 | - | $250.04M(-9.1%) |
| Sep 2009 | - | $274.94M(-4.5%) |
| Mar 2009 | $283.94M(+74.6%) | $287.90M(+7.3%) |
| Dec 2008 | - | $268.40M(+20.3%) |
| Sep 2008 | - | $223.17M(+8.5%) |
| Jun 2008 | - | $205.63M(+20.9%) |
| Mar 2008 | $162.59M(-9.5%) | $170.10M(-14.0%) |
| Dec 2007 | - | $197.85M(-6.5%) |
| Sep 2007 | - | $211.60M(+20.1%) |
| Jun 2007 | - | $176.16M(+0.6%) |
| Mar 2007 | $179.72M(+56.9%) | $175.09M(+27.6%) |
| Dec 2006 | - | $137.23M(-35.9%) |
| Sep 2006 | - | $214.25M(+1.5%) |
| Jun 2006 | - | $211.06M(+95.2%) |
| Mar 2006 | $114.54M(+30.9%) | $108.12M(+7.8%) |
| Dec 2005 | - | $100.29M(+1.1%) |
| Sep 2005 | - | $99.18M(+9.6%) |
| Jun 2005 | - | $90.50M(+10.0%) |
| Mar 2005 | $87.51M(-5.0%) | $82.26M(-4.1%) |
| Dec 2004 | - | $85.77M(-4.0%) |
| Sep 2004 | - | $89.34M(-1.5%) |
| Jun 2004 | - | $90.73M(+5.2%) |
| Mar 2004 | $92.08M(+17.5%) | $86.27M(-5.4%) |
| Dec 2003 | - | $91.15M(-1.4%) |
| Sep 2003 | - | $92.46M(+1.8%) |
| Jun 2003 | - | $90.79M(+21.6%) |
| Mar 2003 | $78.37M(-5.6%) | $74.64M(-6.5%) |
| Dec 2002 | - | $79.83M(+1.8%) |
| Sep 2002 | - | $78.41M(+6.6%) |
| Jun 2002 | - | $73.53M(-5.9%) |
| Mar 2002 | $83.01M(+35.8%) | $78.11M(-3.2%) |
| Dec 2001 | - | $80.69M(-12.3%) |
| Sep 2001 | - | $92.00M(+65.2%) |
| Jun 2001 | - | $55.68M |
| Mar 2001 | $61.13M(+108.0%) | - |
| Mar 2000 | $29.38M(-12.3%) | - |
| Mar 1999 | $33.49M(+12.2%) | - |
| Mar 1998 | $29.85M(+2.3%) | - |
| Mar 1997 | $29.17M(+13.0%) | - |
| Mar 1996 | $25.80M(+26.2%) | - |
| Mar 1995 | $20.45M | - |
FAQ
- What is Dr. Reddy's Laboratories Limited annual accounts receivable?
- What is the all time high annual accounts receivable for Dr. Reddy's Laboratories Limited?
- What is Dr. Reddy's Laboratories Limited annual accounts receivable year-on-year change?
- What is Dr. Reddy's Laboratories Limited quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Dr. Reddy's Laboratories Limited?
- What is Dr. Reddy's Laboratories Limited quarterly accounts receivable year-on-year change?
What is Dr. Reddy's Laboratories Limited annual accounts receivable?
The current annual accounts receivable of RDY is $1.06B
What is the all time high annual accounts receivable for Dr. Reddy's Laboratories Limited?
Dr. Reddy's Laboratories Limited all-time high annual accounts receivable is $1.06B
What is Dr. Reddy's Laboratories Limited annual accounts receivable year-on-year change?
Over the past year, RDY annual accounts receivable has changed by +$95.11M (+9.88%)
What is Dr. Reddy's Laboratories Limited quarterly accounts receivable?
The current quarterly accounts receivable of RDY is $1.11B
What is the all time high quarterly accounts receivable for Dr. Reddy's Laboratories Limited?
Dr. Reddy's Laboratories Limited all-time high quarterly accounts receivable is $1.11B
What is Dr. Reddy's Laboratories Limited quarterly accounts receivable year-on-year change?
Over the past year, RDY quarterly accounts receivable has changed by +$136.92M (+14.08%)